Article Versions Notes

Cahill C, O’Connell F, Gogan KM, Cox DJ, Basdeo SA, O’Sullivan J, Gordon SV, Keane J, Phelan JJ. The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG. International Journal of Molecular Sciences. 2021; 22(6):2938. https://doi.org/10.3390/ijms22062938

Cahill, Christina, Fiona O’Connell, Karl M. Gogan, Donal J. Cox, Sharee A. Basdeo, Jacintha O’Sullivan, Stephen V. Gordon, Joseph Keane, and James J. Phelan. 2021. "The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG" International Journal of Molecular Sciences 22, no. 6: 2938. https://doi.org/10.3390/ijms22062938

Cahill, C., O’Connell, F., Gogan, K. M., Cox, D. J., Basdeo, S. A., O’Sullivan, J., Gordon, S. V., Keane, J., & Phelan, J. J. (2021). The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG. International Journal of Molecular Sciences, 22(6), 2938. https://doi.org/10.3390/ijms22062938